8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Brain & Nervous System

Long-lasting anti-tremor induced by 2-Br-alpha-ergocryptine in monkeys

Bioeffects Seen

Miyamoto T, Battista A, Goldstein M, Fuxe M · 1974

Share:

1974 monkey study showed dopamine-stimulating drugs could provide long-lasting tremor relief, highlighting neurological pathways now known to be EMF-sensitive.

Plain English Summary

Summary written for general audiences

This 1974 study examined whether a dopamine-stimulating drug called 2-Br-α-ergocryptine (CB 154) could provide long-lasting relief from surgically-induced tremor in monkeys. Researchers found that repeated administration of this ergot alkaloid successfully reduced tremor symptoms for extended periods in monkeys with specific brain lesions.

Why This Matters

While this study appears to focus on pharmaceutical interventions for movement disorders rather than EMF exposure, it's worth noting that this research occurred during the early era of EMF health investigations when researchers were exploring various mechanisms of neurological disruption. The study's focus on dopamine receptor stimulation is particularly relevant because modern research shows that EMF exposure can disrupt dopamine signaling pathways in the brain. What's concerning is how little we understood about electromagnetic influences on neurological function in 1974, yet we were already introducing powerful wireless technologies into daily life. The reality is that dopamine systems affected by pharmaceutical agents in this monkey study are the same systems that current research suggests may be vulnerable to chronic EMF exposure from our wireless devices.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Miyamoto T, Battista A, Goldstein M, Fuxe M (1974). Long-lasting anti-tremor induced by 2-Br-alpha-ergocryptine in monkeys.
Show BibTeX
@article{long_lasting_anti_tremor_induced_by_2_br_alpha_ergocryptine_in_monkeys_g7081,
  author = {Miyamoto T and Battista A and Goldstein M and Fuxe M},
  title = {Long-lasting anti-tremor induced by 2-Br-alpha-ergocryptine in monkeys},
  year = {1974},
  
  
}

Quick Questions About This Study

2-Br-α-ergocryptine (CB 154) is an ergot alkaloid that stimulates dopamine receptors in the brain. This 1974 study showed it could provide sustained relief from tremor symptoms in monkeys by activating the same neurological pathways that control movement and coordination.
The researchers created ventromedial tegmental lesions in monkeys to surgically induce tremor symptoms, mimicking movement disorders like Parkinson's disease. This allowed them to test whether the dopamine-stimulating drug could restore normal movement function in a controlled experimental model.
The study demonstrated 'long-lasting' tremor relief with repeated CB 154 administration, though specific duration wasn't detailed in the available abstract. The emphasis on sustained effects distinguished this treatment from shorter-acting interventions previously tested in similar monkey models.
This research identified dopamine receptor pathways crucial for movement control. Modern EMF research shows these same dopamine systems can be disrupted by wireless radiation, making this early neurological work relevant for understanding how electromagnetic fields might affect brain function.
The study mentions that similar dopamine-stimulating agents like L-dopa could cause involuntary movements alongside tremor relief. However, the specific side effect profile of CB 154 in these monkeys wasn't detailed in the available research summary.